0001209191-24-002088.txt : 20240123
0001209191-24-002088.hdr.sgml : 20240123
20240123171006
ACCESSION NUMBER: 0001209191-24-002088
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240121
FILED AS OF DATE: 20240123
DATE AS OF CHANGE: 20240123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cadoret-Manier Onaiza
CENTRAL INDEX KEY: 0001799355
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40928
FILM NUMBER: 24553413
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
STREET 2: C/O IONIS PHARMACEUTICALS, INC.
CITY: CARLSBAD
STATE: CA
ZIP: 92010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ventyx Biosciences, Inc.
CENTRAL INDEX KEY: 0001851194
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 832996852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12790 EL CAMINO REAL, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 945-2393
MAIL ADDRESS:
STREET 1: 12790 EL CAMINO REAL, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-21
0
0001851194
Ventyx Biosciences, Inc.
VTYX
0001799355
Cadoret-Manier Onaiza
C/O VENYTX BIOSCINECES, INC.
12790 EL CAMINO REAL, SUITE 200
SAN DIEGO
CA
92130
1
0
0
0
0
Stock Option (right to buy)
1.97
2024-01-21
4
A
0
20000
0.00
A
2034-01-21
Common Stock
20000
20000
D
The shares subject to the option shall vest on the one-year anniversary of January 21, 2024, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan, the "Plan") through such date, provided that in the event of a Change in Control (as such term is defined in the Plan), one hundred percent (100%) of the then-unvested and outstanding shares subject to the Option will accelerate and fully vest, subject to the reporting person continuing to be an Outside Director (as the term is defined in the Company's Amended and Restated Outside Director Compensation Policy) through the date of the Change in Control.
/s/ Christopher Krueger, as Attorney-in-Fact
2024-01-23